Skip to main content
. 2018 Apr 6;9(26):18341–18350. doi: 10.18632/oncotarget.24836

Figure 2. Engraftment of VR-ALL cells into NOG mice.

Figure 2

5 × 106 VR-ALL cells were injected via the tail vein into 8 to 12 week-old mice. Mice were either (A) sacrificed (n = 4) at 8 weeks following the initial injection of VR-ALL cells to evaluate leukemic burden in organs as levels of hCD45+ cells, or (B) monitored (n = 4) for their survival. “Sham”: control or naive mice.